Sustainable AquaBounty GMO salmon, blocked in US, offers way out of ‘deadly spiral of overfishing’

c e e bd ae e extra large

One day in 1992, a technology entrepreneur sat down for a meeting with a pair of biologists who were studying the genes of fish. The scientists, Choy Hew and Garth Fletcher, were working on a method of purifying “antifreeze proteins” that would help Atlantic salmon (Salmo salar) survive so-called superchill events in the North Atlantic. Normally these salmon migrate out of the subzero ice-laden seawater of the far North Atlantic to overwinter in less frigid waters. Increasingly, though, such fish were being farmed, penned year-round in offshore cages, in near-Arctic waters to which they were not adapted. Fish farmers were looking for a way to keep the fish alive through the winter, and the antifreeze protein seemed like a possible solution.

af b bdef c a extra largeAs the meeting drew to a close, Fletcher and Hew showed Elliot Entis, the entrepreneur, a photo of two fish of equal age. One dwarfed the other. “I sat back down,” Entis recalled recently.

Those salmon, grown and marketed by a company called AquaBounty Technologies that was founded by Entis, could be coming to U.S. grocery stores next year. And they could offer a way out of the deadly spiral of overfishing that is decimating wild fish stocks.

Genetically engineered fish could provide a solution, taking the pressure off wild stocks and reducing the energy and carbon emissions required to feed the world’s seafood appetite. Because AquaBounty’s salmon are sterile and raised in land-based tanks, they can’t breed with wild populations. And because they efficiently convert fish feed into edible protein, they offer a potential low-cost solution for nourishing not only affluent consumers in North America but hungry people in the developing world with little access to meat.

Read full, original post: One Fish, Two Fish, Strange Fish, New Fish

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-09-17 at 12.41
Misinformation alert: No, glyphosate use in Canadian forests is not spurring more wildfires
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
Screenshot 2026-07-16 at 8.49
Pete Hegseth’s bizarre Viagra commercial as Trump administration endorses ‘hormone replacement therapy’

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.